The Head of Strategy of Catapult UK, Fungayi Chidothe, has explained the British innovation promotion programme’s strategy to the partners of the Advance(cat) project. In his talk as a guest of honour at the meeting, held on 26-27 July, Mr Chidothe set out the results obtained by Catapult’s innovation strategy: 200 collaborations in 24 different countries that have resulted in the launching up to now of 67 research projects, including preclinical studies, clinical trials, of industry and analytical techniques.
At the third quarterly meeting of Advance(cat), the BMF presented its animal model of selective geographic atrophy and its potential use for regenerative medicine with cell therapy. During the meeting, the Advance(cat) project held its General Assembly in the Aula Magna of the Clinical Hospital. Here, each of the consortium’s 18 partners presented their capacities, the techniques and models they are developing, their collaborations and their specific contribution to the Advance(cat) to students, postdoctoral fellows, technicians, etc. with the aim of networking. Eduardo Rodríguez Bocanegra, the BMF researcher, explained the research being conducted at the Foundation and gave details about its direct contribution to Advance(cat).
Advance(cat) is funded by the Agency for Business Competitiveness (ACCIÓ) of the Government of Catalonia and the European Union through the ERDF (European Regional Development Fund) operative programme, Catalonia 2014-2020.